 MOUNT VERNON, NY ACCESSWIRE July 16, 2021 Applied UV, Inc. NASDAQ:AUVI Applied UV or the Company, an infection prevention technology company that applies the power of narrow-range ultra violet light UVC to destroy pathogens safely, thoroughly, and automatically, today announced the closing of its underwritten registered public offering of 480,000 shares of 10.5 Series A Cumulative Perpetual Preferred Stock, with liquidation preference of 25.00 per share the Series A Preferred Stock, at an initial public offering price of 25.00 per share, raising gross proceeds of 12.0 million before deducting underwriting discounts and other offering expenses. In connection with the offering, the Company has granted the underwriters a 45-day option to purchase up to an additional 72,000 shares of Series A Preferred Stock. 